HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,639,743 | +52.8% | 29,468 | +45.2% | 0.00% | – |
| Q2 2023 | $1,727,576 | -43.2% | 20,291 | -44.8% | 0.00% | – |
| Q1 2023 | $3,039,987 | +133.4% | 36,737 | +121.8% | 0.00% | – |
| Q4 2022 | $1,302,602 | -30.4% | 16,562 | -34.5% | 0.00% | – |
| Q3 2022 | $1,871,000 | -95.6% | 25,281 | -96.2% | 0.00% | -100.0% |
| Q2 2022 | $42,963,000 | +2057.9% | 659,144 | +1992.5% | 0.01% | – |
| Q1 2022 | $1,991,000 | -86.2% | 31,500 | -88.4% | 0.00% | -100.0% |
| Q4 2021 | $14,451,000 | +94.5% | 272,475 | +158.9% | 0.00% | 0.0% |
| Q3 2021 | $7,429,000 | -57.4% | 105,239 | -59.8% | 0.00% | -50.0% |
| Q2 2021 | $17,425,000 | +430.0% | 261,478 | +782.6% | 0.00% | – |
| Q1 2021 | $3,288,000 | -65.1% | 29,625 | -62.7% | 0.00% | -100.0% |
| Q4 2020 | $9,434,000 | +3.3% | 79,445 | -24.1% | 0.00% | 0.0% |
| Q3 2020 | $9,136,000 | -41.8% | 104,711 | -40.3% | 0.00% | -60.0% |
| Q2 2020 | $15,708,000 | +30.6% | 175,390 | +45.3% | 0.01% | 0.0% |
| Q1 2020 | $12,027,000 | -27.5% | 120,683 | -16.4% | 0.01% | -28.6% |
| Q4 2019 | $16,585,000 | +200.0% | 144,335 | +229.4% | 0.01% | +133.3% |
| Q3 2019 | $5,528,000 | +185.1% | 43,818 | +171.9% | 0.00% | +200.0% |
| Q2 2019 | $1,939,000 | -63.1% | 16,115 | -73.1% | 0.00% | -50.0% |
| Q1 2019 | $5,250,000 | +323.4% | 60,014 | +384.0% | 0.00% | – |
| Q4 2018 | $1,240,000 | -78.4% | 12,400 | -75.3% | 0.00% | -100.0% |
| Q3 2018 | $5,745,000 | -77.9% | 50,136 | -82.7% | 0.00% | -76.9% |
| Q2 2018 | $25,987,000 | +626.1% | 289,780 | +492.4% | 0.01% | +550.0% |
| Q1 2018 | $3,579,000 | -18.7% | 48,918 | -35.4% | 0.00% | -33.3% |
| Q4 2017 | $4,400,000 | +547.1% | 75,744 | +352.2% | 0.00% | +200.0% |
| Q1 2017 | $680,000 | +91.0% | 16,749 | +70.6% | 0.00% | – |
| Q3 2016 | $356,000 | -90.6% | 9,820 | -92.5% | 0.00% | -100.0% |
| Q2 2016 | $3,789,000 | +44.0% | 130,709 | +73.7% | 0.00% | +33.3% |
| Q1 2016 | $2,632,000 | +13.6% | 75,241 | +4.7% | 0.00% | 0.0% |
| Q4 2015 | $2,317,000 | -17.0% | 71,870 | -16.7% | 0.00% | 0.0% |
| Q3 2015 | $2,790,000 | +26.6% | 86,315 | +62.0% | 0.00% | +50.0% |
| Q2 2015 | $2,204,000 | -12.1% | 53,293 | -4.5% | 0.00% | 0.0% |
| Q1 2015 | $2,506,000 | -54.0% | 55,778 | -61.7% | 0.00% | -60.0% |
| Q4 2014 | $5,446,000 | -20.5% | 145,541 | -25.8% | 0.01% | -28.6% |
| Q3 2014 | $6,850,000 | +28.6% | 196,184 | +29.9% | 0.01% | +16.7% |
| Q2 2014 | $5,326,000 | -30.2% | 150,970 | -35.6% | 0.01% | -33.3% |
| Q1 2014 | $7,634,000 | +1483.8% | 234,262 | +1838.1% | 0.01% | +800.0% |
| Q3 2013 | $482,000 | -85.8% | 12,087 | -85.3% | 0.00% | -83.3% |
| Q2 2013 | $3,396,000 | – | 82,126 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |